Soros Fund Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-125,000
| Closed | -$2.02M | – | 229 |
|
|
2025
Q1 | $2.02M | Sell |
125,000
-125,000
| -50% | -$2.02M | 0.03% | 169 |
|
|
2024
Q4 | $5.82M | Buy |
250,000
+105,000
| +72% | +$2.44M | 0.09% | 135 |
|
|
2024
Q3 | $4.26M | Hold |
145,000
| – | – | 0.06% | 124 |
|
|
2024
Q2 | $3.41M | Buy |
145,000
+114,962
| +383% | +$2.7M | 0.06% | 133 |
|
|
2024
Q1 | $1.14M | Buy |
+30,038
| New | +$1.14M | 0.02% | 152 |
|
|
2018
Q3 | – | Sell |
-8,256
| Closed | -$2.18M | – | 217 |
|
|
2018
Q2 | $2.18M | Buy |
+8,256
| New | +$2.18M | 0.04% | 173 |
|